(Reuters) – Johnson & Johnson said on Monday that its unit, Janssen Pharmaceutica NV, entered into a deal with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate.
The company said that the delivery of these vaccines to African Union’s 55 member states will begin in the third quarter of 2021. (https://refini.tv/3cyeFiB)
(Reporting by Nandakumar D in Bengaluru; Editing by Shailesh Kuber)
